Linnaeus Therapeutics
Todd is the newest Board member. He is a partner and the COO/CFO of Kairos Ventures, the lead investor. In his prior life, Todd was the CFO of Citigroup, and he has deep experience in M&A strategy. He will be very helpful as the company enters the next stage of the Linnaeus life cycle.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Linnaeus Therapeutics
Linnaeus Therapeutics, Inc. is a privately-held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics that target G protein-coupled receptors.